CCNG1 and neoplasm: Administration of a dominant negative form of cyclin G1, also known as Rexin-G, using retroviral vector injection into the hepatic artery, has also been tested in the liver metastasis of colorectal tumors (NCT00035919) and has shown significant anti-tumor activity in pancreatic cancer [48].